Cargando…

gC1qR: A New Target for Cancer Immunotherapy

Although breakthroughs in cancer treatment have been achieved, immunotherapy yields only modest benefits in most patients. There is still a gap in clarifying the immune evasiveness and immune-resistance mechanisms. Identifying other candidate targets for cancer immunotherapy is therefore a clear unm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yanna, Li, Xiaoyu, Qin, Diyuan, Zhang, Yugu, Wang, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909189/
https://www.ncbi.nlm.nih.gov/pubmed/36776869
http://dx.doi.org/10.3389/fimmu.2023.1095943

Ejemplares similares